Did John McCain Have Brain Surgery? What to Know

Key Facts

In July 2017, John McCain underwent surgery to remove a blood clot at the base of his brain, which was discovered while he was recovering from a head injury. The clot was not a brain tumor; however, in August 2017 he was diagnosed with glioblastoma, an aggressive form of brain cancer, and received treatment including chemotherapy and radiation. McCain died in August 2018. This page explains the type of procedure, the conditions treated, treatment timeline, and prognosis based on authoritative reports.

Context and Initial Surgery

Head Injury and Clot Discovery

In late May 2017, McCain was admitted to a hospital in Arizona after suffering a head injury during a bicycle crash. Imaging revealed a blood clot beneath the surface of the brain. On May 28, 2017, doctors performed a minimally invasive procedure at Baylor Medical Center at McKinney to relieve pressure by removing the clot. This surgery was treated as an emergency to prevent stroke or neurological decline.

Type of Procedure

The surgery was a craniotomy with clot evacuation, described as a craniectomy in some reports, involving temporary removal of a skull portion to access and remove the clot. It was necessary due to the clot’s location near critical brain structures. As an inpatient, McCain was monitored for complications such as infection, bleeding, and swelling, with gradual mobilization as neurological status allowed.

Diagnosis and Subsequent Treatment

Glioblastoma Diagnosis

After the clot was removed, tissue pathology revealed atypical cells, leading to a glioblastoma diagnosis in August 2017. Glioblastoma is a fast-growing brain cancer that required multimodal therapy. McCain’s medical team outlined a treatment plan including maximal safe resection (when possible), radiation, and chemotherapy, with goals of controlling disease and preserving quality of life.

Postoperative Care and Therapy

McCain continued recovery at Walter Reed National Military Medical Center. His treatment regimen aligned with standard care for glioblastoma, incorporating radiation and temozolomide chemotherapy. Regular MRI scans tracked tumor response, and rehabilitation addressed cognitive and physical function. Family statements noted side effects but emphasized pursuit of treatment options consistent with his preferences.

Prognosis and Outcomes

Glioblastoma carries a guarded prognosis; median survival with standard treatment is approximately 12–18 months, though individual outcomes vary based on age, genetics, and extent of resection. McCain’s team communicated that his cancer was terminal, and in August 2018, his family announced he had entered hospice care at his home in Arizona. He passed away on August 25, 2018, with pneumonia and glioblastoma cited as underlying causes.

Attribute	Verified Detail	Source Type
Date of initial surgery	May 28, 2017	Hospital statement
Condition treated by initial surgery	Blood clot (hematoma)	Medical reports
Procedure type	Craniotomy/craniectomy with clot evacuation	Neurosurgical summary
Diagnosis after clot removal	Glioblastoma	Pathology results
Date of glioblastoma diagnosis	August 2017	Family/team announcement
Date of death	August 25, 2018	Official statement

Treatment Considerations

Management of glioblastoma involves balancing efficacy and quality of life. Options may include awake craniotomy for mapping eloquent areas, radiation fractionation, and chemotherapy. Decisions are individualized; McCain’s care reflected a focus on comfort and goals of care. Clinical trials and experimental therapies were considered but not pursued as primary treatment, consistent with his care philosophy.

Recovery and Rehabilitation

After the initial surgery, McCain experienced typical postoperative recovery, with attention to neurological monitoring. Rehabilitation addressed potential speech, motor, or cognitive changes. For glioblastoma treatment, rehabilitation supports function and independence when possible, with palliative care integrated to manage symptoms and stress for patients and families.

Public Communication and Transparency

McCain’s office and family provided periodic updates, clarifying the distinction between the emergency clot surgery and the terminal cancer diagnosis. These statements helped correct early confusion and set realistic expectations about prognosis. Open communication aimed to respect privacy while informing the public about his health journey.

Common Questions

Was the brain surgery for a tumor? The initial surgery addressed a blood clot, not a tumor; glioblastoma was diagnosed afterward.
What caused his death? McCain died from complications including pneumonia and progressive glioblastoma.
Could the outcome have been different? Outcomes vary; glioblastoma remains challenging, with current treatments focused on延长生存期 and quality of life.
Where did he receive treatment? Care occurred at Baylor Medical Center in Arizona and Walter Reed National Military Medical Center in Maryland.

Summary

John McCain’s medical history involved two distinct neurological events: an emergency surgery for a blood clot in May 2017 and a later diagnosis of glioblastoma. The procedures and goals shifted from urgent clot removal to cancer-directed therapy. Understanding these steps clarifies the difference between acute neurosurgical intervention and long-term cancer management. His case illustrates the complexities of treating serious brain conditions and the importance of aligning care with patient values.

References

Information compiled from hospital statements, official announcements, and peer-reviewed oncology guidelines on glioblastoma management. Key dates and procedures are documented in medical and news reports from 2017–2018.